Edition:
United Kingdom

Swedish Orphan Biovitrum AB (publ) (SOBIV.ST)

SOBIV.ST on Stockholm Stock Exchange

112.20SEK
4:28pm GMT
Change (% chg)

-0.10kr (-0.09%)
Prev Close
112.30kr
Open
112.20kr
Day's High
113.40kr
Day's Low
111.70kr
Volume
459,661
Avg. Vol
604,726
52-wk High
143.80kr
52-wk Low
101.60kr

Latest Key Developments (Source: Significant Developments)

Sobi raises outlook as Q3 core profit beats expectations
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Swedish Orphan Biovitrum Ab (Publ) :Swedish orphan biovitrum q3 ‍ebita was sek 536 m (282)​.Swedish orphan biovitrum says ‍sobi now expects total revenues for full year to be in range of sek 6,300 to 6,400 m (6,100-6,200)​.Swedish orphan biovitrum says ‍gross margin is expected to be around 70 per cent​.Swedish orphan biovitrum q3 ‍total revenue was sek 1,601 m​.Swedish orphan biovitrum says ‍now expects ebita for full year to be in range of sek 1,900 to 2,000 m (1,700-1,800)​.Swedish orphan biovitrum says ‍growth strategy has been designed to capitalise on substantial potential in haemophilia​.Swedish orphan biovitrum says ‍based on this solid platform we will further balance business with a broader specialty care portfolio to ensure a sustainable company in both short and long-term​.Swedish orphan biovitrum says to decentralise decision making towards the country organisations, resource allocation to support this strategic initiative will be reflected accordingly‍​.Swedish orphan biovitrum says we are rebalancing our geographical footprint in our existing markets by, among other things, scaling and developing our north american franchise‍​.Swedish orphan biovitrum says the strengthening of our late stage research and development pipeline is another key area of focus going forward‍​.Reuters poll: sobi q3 ebita was seen at 509 million sek, revenues at 1,636 million.  Full Article

Sobi's CEO divests a portion of shares
Monday, 8 Aug 2016 

: Swedish Orphan Biovitrum (SOBI) says: . CEO Geoffrey McDonough has divested 300,000 of shares he holds in company. .The sale was made for personal financial reasons. After the transaction, McDonough will hold a total of 347,948 shares in the company..  Full Article

Sobi says to repurchase shares
Friday, 15 Jul 2016 

Swedish Orphan Biovitrum Publ AB (SOBI) : Says the board of directors exercises its authorisation for repurchase of shares to secure the company's commitments under the incentive programme . Says repurchase of the class C shares may be effected during the period 15 July - 27 September 2016 .Says the class C shares will, following the repurchase, be converted to common shares.  Full Article

SOBI Q2 EBITA above forecast
Friday, 15 Jul 2016 

Swedish Orphan Biovitrum : Q2 total revenue was sek 1,469 mln (764) . Q2 EBITA was sek 550 mln (74) . Q2 revenues include a sek 386 mln one-time credit from biogen triggered by first commercial sales of alprolix . Q2 gross margin was 72 per cent (63) . Outlook 2016 unchanged .Reuters poll: Sobi Q2 EBITA was seen at sek 435 mln, revenues at 1,317 mln.  Full Article

Pharming Group amends Ruconest distribution agreement with Sobi
Thursday, 14 Jul 2016 

Pharming Group NV : Pharming amends ruconest distribution agreement with Sobi . Pharming to directly commercialise Ruconest in 21 additional Western European, North African and Middle-Eastern markets .Pharming will expand current small European team of experienced hae marketing and medical affairs specialists.  Full Article

Sobi says CEO divests 230,000 shares
Monday, 16 May 2016 

Swedish Orphan Biovitrum (Sobi) : Says CEO Geoffrey McDonough has divested 230,000 of the shares he holds in the company . Says the sale was made in part to pay the estimated US tax due relating to the vesting of the company's 2013 long-term incentive programme, and to prepare to invest in the upcoming 2016 long-term incentive programme should it be approved by the Annual General Meeting later this month .  Full Article

Swedish Orphan Biovitrum says outgoing chairman sells 8 million shares
Wednesday, 4 May 2016 

Swedish Orphan Biovitrum publ AB (SOBI):Outgoing chairman Bo Jesper Hansen has sold 8 million shares.Hansen now owns 893,846 shares in SOBI.  Full Article

Swedish Orphan Biovitrum extends manufacturing agreements with Pfizer
Friday, 29 Apr 2016 

Swedish Orphan Biovitrum publ AB:Sobi signs manufacturing agreements with Pfizer.The agreement has been extended until Dec 31, 2023.  Full Article

Swedish Orphan Biovitrum keeps FY 2016 outlook unchanged
Wednesday, 27 Apr 2016 

Swedish Orphan Biovitrum publ AB:Says continues to expect total revenue for FY 2016 to be in the range of 4.80 billion Swedish crowns to 5.00 billion crowns.Gross margin is expected be in the range of 68 to 70 percent.Expects EBITA for FY 2016 to be in the range of 1.20 billion to 1.30 billion crowns.  Full Article

Swedish Orphan Biovitrum signs licensing agreement with Affibody for IL-1
Friday, 22 Apr 2016 

Swedish Orphan Biovitrum publ AB:Says signs licensing agreement with Affibody for IL-1.Exercised its option to sign licensing agreement with Swedish biotech company Affibody AB for development of novel treatments for inflammatory diseases where interleukin-1 (IL-1) is involved.  Full Article

BRIEF-Sobi says wins approval from Health Canada for Orfadin for treatment of HT-1‍​

* SAYS WINS APPROVAL FROM HEALTH CANADA FOR ORFADIN ORAL SUSPENSION FOR TREATMENT OF HT-1‍​ Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)